Implantation or Injectable Dosage Form New Animal Drugs; Estradiol and Testosterone, Progesterone and Estradiol, Trenbolone, and Trenbolone and Estradiol, With Tylosin
other · Food and Drug Administration · Rule · Published 1999-09-03 · Effective 1999-09-03 · 64 FR 48293
Document
Document number
99-22995
Federal Register citation
64 FR 48293
CFR reference
21 CFR 510
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1999-09-03
Effective date
1999-09-03
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of four supplemental applications filed by Ivy Laboratories, Div. of Ivy Animal Health, Inc., two supplemental new animal drug applications (NADA's) and two supplemental abbreviated new animal drug applications (ANADA's). The supplemental applications provide for addition of tylosin as a local antibacterial to estradiol/testosterone, progesterone/estradiol, trenbolone, and trenbolone/estradiol cattle ear implants. The products are subcutaneous implants for cattle for weight gain and/or feed efficiency.